Apremilast Use for Moderate-to-Severe Atopic Dermatitis in Pediatric Patients

Publisher： Karger

E-ISSN： 1662-6567|8|2|179-184

ISSN： 1662-6567

Source： Case Reports in Dermatology, Vol.8, Iss.2, 2016-07, pp. : 179-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Percutaneous Absorption of Pimecrolimus Is Not Increased in Patients with Moderate to Severe Atopic Dermatitis when Pimecrolimus Cream 1% Is Applied under Occlusion

By  

Dermatology, Vol. 221, Iss. 4, 2010-11 ,pp. : 342-351

Karger

Access to resources Recommend Favorite

Extracorporeal Photopheresis as a Treatment for Patients with Severe, Refractory Atopic Dermatitis

By  

Dermatology, Vol. 215, Iss. 2, 2007-08 ,pp. : 134-138

Karger

Access to resources Recommend Favorite

Adalimumab in Recalcitrant Severe Psoriasis Associated with Atopic Dermatitis

By  

Case Reports in Dermatology, Vol. 5, Iss. 3, 2013-11 ,pp. : 332-335

Karger

Access to resources Recommend Favorite

Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial

By  

Dermatology, Vol. 221, Iss. 2, 2010-07 ,pp. : 172-178

Karger

Access to resources Recommend Favorite

Once-Weekly Administration of Etanercept 50 mg Improves Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis

By  

Dermatology, Vol. 219, Iss. 3, 2009-09 ,pp. : 239-249

Karger

Access to resources Recommend Favorite